Truvestments Capital’s Covetrus, Inc. Common Stock CVET Stock Holding History

Truvestments Capital’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-375	Closed	-$8K	–	979
2022 Q3	$8K	Hold	375	–	–	0.01%	438
2022 Q2	$8K	Buy	+375	New	+$6.67K	﹤0.01%	443
2022 Q1	–	Sell	-375	Closed	-$7K	–	607
2021 Q4	$7K	Hold	375	–	–	﹤0.01%	448
2021 Q3	$7K	Buy	375 +150	+67%	+$3.44K	﹤0.01%	427
2021 Q2	$6K	Hold	225	–	–	﹤0.01%	448
2021 Q1	$7K	Buy	+225	New	+$7.67K	﹤0.01%	495
2020 Q3	–	Sell	-1,000	Closed	-$17K	–	593
2020 Q2	$17K	Hold	1,000	–	–	0.02%	328
2020 Q1	$8K	Buy	+1,000	New	+$11.4K	0.01%	380

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Truvestments Capital's CVET Position: Q4 2022 in Review

Truvestments Capital sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 375 shares — an estimated $8K sold.

Truvestments Capital first reported a position in CVET in Q1 2020 and held it in 8 quarters. The position peaked at $17K in Q2 2020. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Truvestments Capital reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Truvestments Capital sold 375 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $8K.
Truvestments Capital first reported a position in Covetrus, Inc. Common Stock in Q1 2020 and held it in 8 quarters.
Truvestments Capital's Covetrus, Inc. Common Stock position peaked at $17K in Q2 2020.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Truvestments Capital's 13F filing for Q4 2022, filed 14 Feb 2023.